Strong numbers. In line with guidance so credit neutral.
- Revenue €6.85bn up 8.1% reported, +7.3% cFX. In line with expectations
- Direct to Consumer leading with +11% cFX; Professional Solutions +5.1%
- Business equally split between the two divisions
- Regionally APAC led with +11% growth
- Confirms mid-single-digit revenue growth 2022-26 at cFX with 19-20% Operating Margin
- Last issued Aug 2024. €1,500m matures May 2025
- Trades in the middle of the single-A health care sector.